Granite Point Capital Management, L.P. Sutro Biopharma, Inc. Transaction History

Granite Point Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$10.16 - $23.98 $1.5 Million - $3.53 Million	-147,219 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$7.44 - $13.15 $20,690 - $36,570	-2,781 Reduced 1.85%	147,219 $1.48 Million
Q2 2020 Aug 12, 2020	BUY	$7.24 - $11.05 $574,580 - $876,950	79,362 Added 112.35%	150,000 $1.16 Million
Q1 2020 May 12, 2020	SELL	$6.19 - $12.16 $181,750 - $357,041	-29,362 Reduced 29.36%	70,638 $721,000
Q4 2019 Feb 10, 2020	BUY	$8.15 - $11.39 $815,000 - $1.14 Million	100,000 New	100,000 $1.1 Million

122

53.3M

7.8K

2.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $197M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.